These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 27614284)

  • 1. Gomesin acts in the immune system and promotes myeloid differentiation and monocyte/macrophage activation in mouse.
    Buri MV; Dias CC; Barbosa CM; Nogueira-Pedro A; Ribeiro-Filho AC; Miranda A; Paredes-Gamero EJ
    Peptides; 2016 Nov; 85():41-45. PubMed ID: 27614284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective topical treatment of subcutaneous murine B16F10-Nex2 melanoma by the antimicrobial peptide gomesin.
    Rodrigues EG; Dobroff AS; Cavarsan CF; Paschoalin T; Nimrichter L; Mortara RA; Santos EL; Fázio MA; Miranda A; Daffre S; Travassos LR
    Neoplasia; 2008 Jan; 10(1):61-8. PubMed ID: 18231639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNA in Macrophage Development and Function.
    Roy S
    Antioxid Redox Signal; 2016 Nov; 25(15):795-804. PubMed ID: 27353423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gomesin, a peptide produced by the spider Acanthoscurria gomesiana, is a potent anticryptococcal agent that acts in synergism with fluconazole.
    Barbosa FM; Daffre S; Maldonado RA; Miranda A; Nimrichter L; Rodrigues ML
    FEMS Microbiol Lett; 2007 Sep; 274(2):279-86. PubMed ID: 17645524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis.
    Sinha P; Clements VK; Ostrand-Rosenberg S
    Cancer Res; 2005 Dec; 65(24):11743-51. PubMed ID: 16357187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide gomesin triggers cell death through L-type channel calcium influx, MAPK/ERK, PKC and PI3K signaling and generation of reactive oxygen species.
    Soletti RC; del Barrio L; Daffre S; Miranda A; Borges HL; Moura-Neto V; Lopez MG; Gabilan NH
    Chem Biol Interact; 2010 Jul; 186(2):135-43. PubMed ID: 20433817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship studies of gomesin: importance of the disulfide bridges for conformation, bioactivities, and serum stability.
    Fázio MA; Oliveira VX; Bulet P; Miranda MT; Daffre S; Miranda A
    Biopolymers; 2006; 84(2):205-18. PubMed ID: 16235231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unlocking the Potential of the Antimicrobial Peptide Gomesin: From Discovery and Structure-Activity Relationships to Therapeutic Applications.
    Liu X; Henriques ST; Craik DJ; Chan LY
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of the antimicrobial peptide gomesin with model membranes: a calorimetric study.
    Domingues TM; Mattei B; Seelig J; Perez KR; Miranda A; Riske KA
    Langmuir; 2013 Jul; 29(27):8609-18. PubMed ID: 23755822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gomesin inhibits melanoma growth by manipulating key signaling cascades that control cell death and proliferation.
    Ikonomopoulou MP; Fernandez-Rojo MA; Pineda SS; Cabezas-Sainz P; Winnen B; Morales RAV; Brust A; Sánchez L; Alewood PF; Ramm GA; Miles JJ; King GF
    Sci Rep; 2018 Aug; 8(1):11519. PubMed ID: 30068931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Cytotoxic Activity in Leukemic Lineages Reveals Important Features of β-Hairpin Antimicrobial Peptides.
    Buri MV; Torquato HFV; Barros CC; Ide JS; Miranda A; Paredes-Gamero EJ
    J Cell Biochem; 2017 Jul; 118(7):1764-1773. PubMed ID: 27987312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclization of the antimicrobial peptide gomesin with native chemical ligation: influences on stability and bioactivity.
    Chan LY; Zhang VM; Huang YH; Waters NC; Bansal PS; Craik DJ; Daly NL
    Chembiochem; 2013 Mar; 14(5):617-24. PubMed ID: 23426877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the antimicrobial peptide gomesin against different life stages of Plasmodium spp.
    Moreira CK; Rodrigues FG; Ghosh A; Varotti Fde P; Miranda A; Daffre S; Jacobs-Lorena M; Moreira LA
    Exp Parasitol; 2007 Aug; 116(4):346-53. PubMed ID: 17376436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to degradation and cellular distribution are important features for the antitumor activity of gomesin.
    Buri MV; Domingues TM; Paredes-Gamero EJ; Casaes-Rodrigues RL; Rodrigues EG; Miranda A
    PLoS One; 2013; 8(11):e80924. PubMed ID: 24312251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties.
    Troeira Henriques S; Lawrence N; Chaousis S; Ravipati AS; Cheneval O; Benfield AH; Elliott AG; Kavanagh AM; Cooper MA; Chan LY; Huang YH; Craik DJ
    ACS Chem Biol; 2017 Sep; 12(9):2324-2334. PubMed ID: 28741926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protection effect of LEAP-2 on the mudskipper (Boleophthalmus pectinirostris) against Edwardsiella tarda infection is associated with its immunomodulatory activity on monocytes/macrophages.
    Chen J; Chen Q; Lu XJ; Chen J
    Fish Shellfish Immunol; 2016 Dec; 59():66-76. PubMed ID: 27765699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in peritoneal myeloid populations and their proinflammatory cytokine expression during infection with Listeria monocytogenes are altered in the absence of gamma/delta T cells.
    Skeen MJ; Freeman MM; Ziegler HK
    J Leukoc Biol; 2004 Jul; 76(1):104-15. PubMed ID: 15107460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2a/Pbx1 oncogene inhibits terminal differentiation but not myeloid potential of pro-T cells.
    Bourette RP; Grasset MF; Mouchiroud G
    Oncogene; 2007 Jan; 26(2):234-47. PubMed ID: 16819510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditional deletion of caspase-8 in macrophages alters macrophage activation in a RIPK-dependent manner.
    Cuda CM; Misharin AV; Khare S; Saber R; Tsai F; Archer AM; Homan PJ; Haines GK; Hutcheson J; Dorfleutner A; Budinger GR; Stehlik C; Perlman H
    Arthritis Res Ther; 2015 Oct; 17():291. PubMed ID: 26471282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN regulatory factor 8 represses GM-CSF expression in T cells to affect myeloid cell lineage differentiation.
    Paschall AV; Zhang R; Qi CF; Bardhan K; Peng L; Lu G; Yang J; Merad M; McGaha T; Zhou G; Mellor A; Abrams SI; Morse HC; Ozato K; Xiong H; Liu K
    J Immunol; 2015 Mar; 194(5):2369-79. PubMed ID: 25646302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.